日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease

人类造血干细胞中 β 珠蛋白基因校正的开发可作为镰状细胞病的潜在持久治疗方法

Annalisa Lattanzi, Joab Camarena, Premanjali Lahiri, Helen Segal, Waracharee Srifa, Christopher A Vakulskas, Richard L Frock, Josefin Kenrick, Ciaran Lee, Narae Talbott, Jason Skowronski, M Kyle Cromer, Carsten T Charlesworth, Rasmus O Bak, Sruthi Mantri, Gang Bao, David DiGiusto, John Tisdale, J Fr

An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol

影响细胞疗法商业化的因素评估:系统评价方案

David Pettitt, Zeeshaan Arshad, Benjamin Davies, James Smith, Anna French, Doug Cole, Kim Bure, Sue Dopson, David DiGiusto, Jeff Karp, Brock Reeve, Richard Barker, Georg Holländer, David Brindley7

Optimized processing of growth factor mobilized peripheral blood CD34+ products by counterflow centrifugal elutriation

逆流离心淘洗法优化生长因子动员外周血CD34+产物的处理

Chy-Anh Tran, Monica Torres-Coronado, Agnes Gardner, Angel Gu, Hieu Vu, Anitha Rao, Lan-Feng Cao, Amira Ahmed, David Digiusto

STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma

STAT3 抑制是 ABC 样弥漫大 B 细胞淋巴瘤的治疗策略

Anna Scuto, Maciej Kujawski, Claudia Kowolik, Ludmila Krymskaya, Lin Wang, Lawrence M Weiss, David Digiusto, Hua Yu, Stephen Forman, Richard Jove